LogicBio Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LogicBio Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2022.
  • LogicBio Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $3.7M, a 23.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $3.7M -$1.15M -23.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $4M -$1.13M -22.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $4.29M -$1.11M -20.6% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $4.57M -$1.09M -19.2% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $4.85M -$1.1M -18.4% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $5.13M -$1.16M -18.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $5.4M +$5.2M +2611% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $5.66M +$5.16M +1023% Dec 31, 2020 10-K 2022-03-04
Q3 2020 $5.95M +$5.28M +789% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $6.29M +$5.32M +550% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $199K -$1.06M -84.2% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $504K Dec 31, 2019 10-K 2021-03-15
Q3 2019 $669K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $967K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $1.26M Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.